Speaker profile

Julie Klint

Director, Head of Molecular Discovery & Enabling Technologies
Lundbeck

Julie Klint, serves as the Director of Molecular Discovery and Enabling Technologies at Lundbeck Research. She earned a Master of Pharmaceutical Sciences from Copenhagen University and a PhD from the University of Queensland, specializing in Ion channel Drug discovery. After a few years as a Research Leader at Evotec AG, Automated Patch Clamp facility in Hamburg, Germany, she joined Lundbeck in Copenhagen, Denmark. At Lundbeck, she is a core member of the Research Leadership team and plays a pivotal role in advancing innovative Drug Discovery projects in the field of Neuroscience. Her leadership is driving research projects, through cutting edge technologies and the integration of Generative AI and predictive modeling to transform drug discovery processes. She is responsible for the Digital strategy of Lundbeck Research and is leading the implementation of Research Scientific data system and application platforms, enhancing lab automation and implementing FAIR data principles.

Agenda sessions

Day 2 | October 1, 2025
11:40 (CEST)
Centralizing Digital Strategy to Optimize the Use of Novel Technologies
Go to session
12:25 (CEST)
Panel Discussion and Q&A
Go to session